Healthcare provider profile · identity verified

Howard E Reeve, MD

Family Practice · MINOT, ND · NPI 1538230677

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	126
Lisinopril	Lisinopril	467	128
Losartan Potassium	Losartan Potassium	415	111
Amlodipine Besylate	Amlodipine Besylate	392	101
Levothyroxine Sodium	Levothyroxine Sodium	369	85
Simvastatin	Simvastatin	340	84
Omeprazole	Omeprazole	312	75
Tamsulosin Hcl	Tamsulosin Hcl	300	85
Hydrochlorothiazide	Hydrochlorothiazide	296	85
Metoprolol Succinate	Metoprolol Succinate	288	77
Potassium Chloride	Potassium Chloride	248	60
Rosuvastatin Calcium	Rosuvastatin Calcium	232	64
Furosemide	Furosemide	228	56
Metformin Hcl Er	Metformin Hcl	192	54
Sertraline Hcl	Sertraline Hcl	182	43
Allopurinol	Allopurinol	175	45
Pantoprazole Sodium	Pantoprazole Sodium	167	43
Azithromycin	Azithromycin	160	103
Metoprolol Tartrate	Metoprolol Tartrate	155	37
Eliquis	Apixaban	150	33
Gabapentin	Gabapentin	150	49
Finasteride	Finasteride	144	43
Atenolol	Atenolol	142	38
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	139	36
Clopidogrel	Clopidogrel Bisulfate	135	39
Jardiance	Empagliflozin	124	25
Glipizide Er	Glipizide	115	30
Albuterol Sulfate Hfa	Albuterol Sulfate	98	31
Tramadol Hcl	Tramadol Hcl	98	21
Metformin Hcl	Metformin Hcl	96	28
Diclofenac Sodium	Diclofenac Sodium	86	28
Cephalexin	Cephalexin	81	59
Warfarin Sodium	Warfarin Sodium	81	18
Donepezil Hcl	Donepezil Hcl	73	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	17
Amoxicillin	Amoxicillin	69	47
Lorazepam	Lorazepam	68	24
Zolpidem Tartrate	Zolpidem Tartrate	68	20
Prednisone	Prednisone	63	24
Spironolactone	Spironolactone	63	18
Duloxetine Hcl	Duloxetine Hcl	61	16
Pravastatin Sodium	Pravastatin Sodium	60	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	17
Celecoxib	Celecoxib	50	20
Verapamil Er	Verapamil Hcl	50	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	33
Alprazolam	Alprazolam	47	suppressed
Ozempic	Semaglutide	47	12
Ezetimibe	Ezetimibe	46	12
Levofloxacin	Levofloxacin	46	31
Famotidine	Famotidine	45	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Propranolol Hcl Er	Propranolol Hcl	43	15
Enalapril Maleate	Enalapril Maleate	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	11
Montelukast Sodium	Montelukast Sodium	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Tresiba Flextouch U-100	Insulin Degludec	38	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Glipizide	Glipizide	34	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	18
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Methylprednisolone	Methylprednisolone	31	22
Trazodone Hcl	Trazodone Hcl	31	suppressed
Fenofibrate	Fenofibrate,micronized	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Glimepiride	Glimepiride	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Jantoven	Warfarin Sodium	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	14
Clonazepam	Clonazepam	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Valsartan	Valsartan	20	suppressed
Verapamil Sr	Verapamil Hcl	20	suppressed
Fentanyl	Fentanyl	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Digoxin	Digoxin	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Primidone	Primidone	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error